Literature DB >> 17921746

New understanding about calcific aortic stenosis and opportunities for pharmacologic intervention.

Luis M Moura1, Kameswari Maganti, Jyothy J Puthumana, F Rocha-Gonçalves, Nalini M Rajamannan.   

Abstract

PURPOSE OF REVIEW: This review article will discuss aortic stenosis, the evolving studies defining the cellular mechanisms and the potential for medical therapies for the treatment of this disease. RECENT
FINDINGS: Currently, the only therapy for these patients is surgical valve replacement. In the past decade there has been a change in the paradigm towards our understanding of the cellular biology of this disease process. Studies in laboratories across the world have demonstrated that this disease has an active biology and that this biology may be targeted with medical therapies similar to that of vascular atherosclerosis.
SUMMARY: Calcific aortic stenosis is the third most common form of cardiovascular disease in the USA. It has replaced rheumatic heart disease in prevalence in western countries due to improved access to healthcare and the widespread use of antibiotics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17921746     DOI: 10.1097/HCO.0b013e3282f0dae6

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  1 in total

1.  Macrophage glucocorticoid receptors join the intercellular dialogue in atherosclerotic lesion calcification.

Authors:  Robert Terkeltaub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-12       Impact factor: 8.311

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.